Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women

Addiction

Volumn 108, Issue 4, 2013, Pages 762-770

  Cleary, Brian J ^a,b,c   Reynolds, Kieran ^b   Eogan, Maeve ^d   O'Connell, Michael P ^a   Fahey, Tom ^b   Gallagher, Paul J ^b   Clarke, Tom ^d   White, Martin J ^a   McDermott, Christine ^d   O'Sullivan, Anne ^a   Carmody, Deirdre ^e   Gleeson, Justin ^e   Murphy, Deirdre J ^a,c  

^a Pathology Research Laboratory   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d ROTUNDA HOSPITAL   (Ireland)

^e HEALTH SERVICE EXECUTIVE   (Ireland)

Author keywords

Dosage; Dosing; Methadone; Neonatal abstinence syndrome; Pregnancy; Withdrawal

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; METHADONE; NARCOTIC AGENT; PRESCRIPTION DRUG;

FEMALE; HUMAN; IRELAND; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PROCEDURES; PROSPECTIVE STUDY; THIRD TRIMESTER PREGNANCY; ARTICLE; METHODOLOGY; OPIATE ADDICTION; PREGNANCY COMPLICATION; WITHDRAWAL SYNDROME;

ANTI-BACTERIAL AGENTS; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; IRELAND; METHADONE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; PRENATAL CARE; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES;

EID: 84891421036     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12078     Document Type: Article

References (33)

1. Mattick R. P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; (3): Art. No.: CD002209. DOI: 10.1002/14651858. CD002209.pub2.
2. Jones H. E., O'Grady K. E., Malfi D., Tuten M. Methadone maintenance versus methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008; 17: 372-86.
3. Jones H. E., Finnegan L. P., Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs 2012; 72: 747-57.
4. Finnegan L. P., Connaughton J. F. Jr, Kron R. E., Emich J. P. Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2: 141-58.
5. Cleary B. J., Donnelly J., Strawbridge J. D., Gallagher P. J., Fahey T., Clarke M. et al. Methadone dose and neonatal abstinence syndrome-systematic review and metaanalysis. Addiction 2010; 105: 2071-84.
6. Dryden C., Young D., Hepburn M., Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. Br J Obstet Gynaecol 2009; 116: 665-71.
7. Patrick S. W., Schumacher R. E., Benneyworth B. D., Krans E. E., McAllister J. M., Davis M. M. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307: 1934-40.
8. Blinick G. Menstrual function and pregnancy in narcotics addicts treated with methadone. Nature 1968; 219: 180.
9. Reddy A. M., Harper R. G., Stern G. Observations on heroin and methadone withdrawal in the newborn. Pediatrics 1971; 48: 353-8.
10. Department of Health (England) and the devolved administrations. Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health (England), The Scottish Government, Welsh Assembly Government and the Northern Ireland Executive; 2007.
11. Chan C., Moriarty H. A special type of 'hard-to-reach' patient: experiences of pregnant women on methadone. J Prim Health Care 2010; 2: 61-9.
12. Pond S. M., Kreek M. J., Tong T. G., Raghunath J., Benowitz N. L. Altered methadone pharmacokinetics in methadonemaintained pregnant women. J Pharmacol Exp Ther 1985; 233: 1-6.
13. Wolff K., Boys A., Rostami-Hodjegan A., Hay A., Raistrick D. Changes to methadone clearance during pregnancy. Eur J Clin Pharmacol 2005; 61: 763-8.
14. Jarvis M. A.,Wu-Pong S., Kniseley J. S., Schnoll S. H. Alterations in methadone metabolism during late pregnancy. J Addict Dis 1999; 18: 51-61.
15. Swift R. M., Dudley M., DePetrillo P., Camara P., GriffithsW. Altered methadone pharmacokinetics in pregnancy: implications for dosing. J Subst Abuse 1989; 1: 453-60.
16. Hieronymus T. L., Nanovskaya T.N., Deshmukh S. V., Vargas R., Hankins G. D. V., Ahmed M. S. Methadone metabolism by early gestational age placentas. Am J Perinatol 2006; 23: 287-94.
17. Szeto H., Umans J., McFarland J. A comparison of morphine and methadone disposition in the maternal-fetal unit. Am J Obstet Gynecol 1982; 143: 700-6.
18. Kaltenbach K., Berghella V., Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin North Am 1998; 25: 139-51.
19. Albright B., de la Torre L., Skipper B., Price S., Abbott P., Rayburn W. Changes in methadone maintenance therapy during and after pregnancy. J Subst Abuse Treat 2011; 41: 347-53.
20. Peles E., Schreiber S., Bloch M., Dollberg S., Adelson M. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction. J Addict Med 2012; 6: 18-23.
21. Dashe J. S., Sheffield J. S.,Wendel G. D. Improving the management of opioid-dependent pregnancies. Am J Obstet Gynecol 2004; 190: 1806.
22. Martin P. R., Arria A. M., Fischer G., Kaltenbach K., Heil S. H., Stine S. M. et al. Psychopharmacologic management of opioid-dependent women during pregnancy. Am J Addict 2009; 18: 148-56.
23. Seligman N. S., Salva N., Hayes E. J., Dysart K. C., Pequignot E. C., Baxter J. K. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol 2008; 199: 396.e1-96.e7.
24. Benningfield M. M., Arria A. M., Kaltenbach K., Heil S. H., Stine S. M., Coyle M. G. et al. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict 2010; 19: 416-21.
25. Cleary B. J., Eogan M., O'Connell M. P., Fahey T., Gallagher P. J., Clarke T. et al. Methadone and perinatal outcomes: a prospective cohort study. Addiction 2012; 107: 1482- 92.
26. Finnegan L. P., Ehrlich S. Maternal drug use during pregnancy: evaluation and pharmacotherapy for neonatal abstinence. In: Adler M. W., Cowan A., editors. Modern Methods in Pharmacology: Testing and Evaluation of Drugs of Abuse. New York: Wiley-Liss Inc.; 1990, p. 255-63.
27. New South Wales Department of Health. National Clinical Guidelines for the Management of Drug Use During Pregnancy, Birth and the Early DevelopmentYears of the Newborn. Sydney: NSW Department of Health; 2006.
28. American Congress of Ostetricians and Gynecologists (ACOG). ACOG Committee opinion no. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol 2012; 119: 1070-6.
29. Center for Substance Abuse Treatment (CSAT). Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43. DHHS Publication No. (SMA) 05-4048. Rockville, Maryland: Substance Abuse and Mental Health Services Administration; 2005.
30. World Health Organization Department of Mental Health Substance Abuse. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, Switzerland: World Health Organization; 2009.
31. Lund I. O., Skurtveit S., Sarfi M., Bakstad B., Welle-Strand G., Ravndal E. A 2-year prospective study of psychological distress among a national cohort of pregnant women in opioid maintenance treatment and their partners. J Subst Use 2012. doi:10.3109/14659891.2011.642928. (online ahead of print).
32. Lewis G. Saving Mothers' Lives: Reviewing Maternal Deaths to Make Motherhood Safer-2006-2008. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: Centre for Maternal and Child Enquiries (CMACE); 2011.
33. McCarthy J. J. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? J Matern Fetal Neonatal Med 2012; 25: 109-12.